:be Aktie
WKN DE: A3CWWB / ISIN: AT0000A2SGH0
20.04.2025 12:20:00
|
Prediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock
Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the announcement that its newest GLP-1 drug had successfully completed the first of several phase 3 drug trials.The jump in share price propelled the stock into positive territory -- it was up nearly 9% year to date as of this writing, and up about 12% over the past 12 months.Let's look at why this news could be a game-changer for Eli Lilly and its stock.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu :be AG Inhaber-Aktmehr Nachrichten
Analysen zu :be AG Inhaber-Aktmehr Analysen
Aktien in diesem Artikel
:be AG Inhaber-Akt | 0,42 | 17,22% |
|